Health 14 September 2026 Uganda Investment Authority
Quality Chemical Industries: A Beacon of WHO-Compliant Pharmaceutical Manufacturing in Sub-Saharan Africa
Quality Chemical Industries Limited (QCIL) is a leading Ugandan pharmaceutical manufacturer, recognized as one of the few WHO-compliant facilities in Sub-Saharan Africa. The company is dedicated to producing affordable, high-quality essential medicines locally for the African continent. Source: https://ugandainvest.go.ug/quality-chemical-industries-one-of-few-who-compliant-pharma-in-sub-saharan-africa
Quality Chemical Industries Limited (QCIL) has emerged as a significant player in Africa’s pharmaceutical landscape, establishing itself as one of the few manufacturers in Sub-Saharan Africa to meet World Health Organization (WHO) compliance standards. Founded by a group of visionary entrepreneurs in 1997, QCIL began its journey in Kampala’s artisanal district, initially focusing on veterinary medicines before pivoting to human health.
The company’s strategic relocation to the Uganda Investment Authority’s Luzira Industrial Park marked a pivotal moment, allowing for the development of a modern, expansive pharmaceutical plant. This facility is now undergoing significant expansion, including a second manufacturing site approved in 2024, and has attracted a key partnership with the Indian pharmaceutical giant, Cipla.
QCIL’s core mission is to manufacture WHO-prequalified medicines, particularly addressing high-burden diseases like HIV/AIDS, malaria, and tuberculosis. This focus not only reduces Africa’s dependence on imported drugs but also bolsters regional health security. The company has made substantial investments, exceeding USD 60 million in pharmaceutical infrastructure, with an additional USD 51 million allocated for its expansion project. This expansion is projected to increase production capacity by approximately one billion tablets annually and introduce injectable drug manufacturing.
Beyond its manufacturing prowess, QCIL is deeply invested in human capital development, offering extensive training programs for pharmacists, graduate traineeships, and internships. The company employs around 600 individuals, with plans to create over 500 new skilled jobs. QCIL’s operations contribute significantly to Uganda’s industrialization, export revenues, and technology transfer, aligning with national priorities for local production and import substitution. Its model of local manufacturing adhering to global quality standards is scalable and replicable across the continent, positioning QCIL as a vital asset for regional medicine security and a testament to African industrial excellence.